Clinical Trial Detail

NCT ID NCT02423915
Title Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors M.D. Anderson Cancer Center
Indications

hematologic cancer

Therapies

Filgrastim

Rituximab

Cyclophosphamide + Fludarabine + Mycophenolate mofetil

Sirolimus

Age Groups: adult child

No variant requirements are available.